Daily Intake of Milk Enriched with n-3 Fatty Acids, Oleic Acid, and Calcium Improves Metabolic and Bone Biomarkers in Postmenopausal Women

Journal of the American College of Nutrition

Volumn 35, Issue 6, 2016, Pages 529-536

  Fonolla Joya, Juristo ^a   Reyes García, Rebeca ^b,e   García Martín, Antonia ^c,e   López Huertas, Eduardo ^d   Muñoz Torres, Manuel ^e  

^a Rafael Méndez Hospital   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c Hospital Comarcal del Noroeste   (Spain)

^d CSIC   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

bone biomarkers; n 3 fatty acids; postmenopausal women

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; DOCOSAHEXAENOIC ACID; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; OMEGA 3 FATTY ACID; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOL; SATURATED FATTY ACID; UNSATURATED FATTY ACID; VITAMIN D; CALCIUM INTAKE; LIPID;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; MIDDLE AGED; MILK; POSTMENOPAUSE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; BONE; BONE REMODELING; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CHEMISTRY; FORTIFIED FOOD; PHYSIOLOGY; RISK FACTOR;

ADULT; ANIMALS; BIOMARKERS; BONE AND BONES; BONE REMODELING; C-REACTIVE PROTEIN; CALCIUM, DIETARY; CARDIOVASCULAR DISEASES; FATTY ACIDS, OMEGA-3; FEMALE; FOOD, FORTIFIED; HUMANS; LIPIDS; MIDDLE AGED; MILK; OLEIC ACID; OSTEOPROTEGERIN; POSTMENOPAUSE; RISK FACTORS;

EID: 84980027646     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2014.1003114     Document Type: Article

References (31)

1. C.J.Lavie, R.V.Milani, M.R.Mehra, H.O.Ventura:Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54:585–594, 2009.
2. J.Fonollá, E.López-Huertas, F.J.Machado, D.Molina, I.Álvarez, E.Mármol, M.Navas, E.Palacín, M.J.García-Valls, B.Remón, J.J.Boza, J.L.Marti:Milk enriched with “healthy fatty acids” improves cardiovascular risk markers and nutritional status in human volunteers. Nutrition 25:408–414, 2009.
3. E.Martín-Bautista, M.Muñoz-Torres, J.Fonollá, M.Quesada, A.Poyatos, E.López-Huertas:Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutr Res 30:320–326, 2010.
4. A.E.Griel, P.M.Kris-Etherton, K.F.Hilpert, G.Zhao, I.G.West, R.L.Corwin:An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6:2, 2007.
5. D.Sun, A.Krishnan, K.Zaman, R.Lawrence, A.Bhattacharya, G.Fernández:Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206–1216, 2003.
6. C.Vanek, W.E.Connor:Do n-3 fatty acids prevent osteoporosis? Am J Clin Nutr 85:647–648, 2007.
7. E.Bairaktari, K.Hatzidimou, C.Tzallas, M.Vini, A.Katsaraki, A.Tselepis, M.Elisaf, O.Tsolas:Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin Biochem 33:549–555, 2000.
8. A.Araki, Y.Sako:Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43–52, 1987.
9. T.Seppänen-Laakso, I.Laakso, H.Vanhanen, K.Kiviranta, T.Lehtimäki, R.Hiltunen:Major human plasma lipid classes determined by quantitative high-performance liquid chromatography, their variation and associations with phospholipid fatty acids. J Chromatogr B Biomed Sci Appl 754:437–445, 2001.
10. E.Lopez-Huertas:Health effects of oleic acid and long chain omega-3 fatty acids (EPA and DHA) enriched milks. A review of intervention studies. Pharmacol Res 61:200–207, 2010.
11. T.Gordon, W.P.Castelli, M.C.Hjortland, W.B.Kannel, T.R.Dawber:High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707–714, 1977.
12. J.J.Carrero, L.Baró, J.Fonollá, M.González-Santiago, A.Martínez-Férez, R.Castillo, J.Jiménez, J.J.Boza, E.López-Huertas:Cardiovascular effects of milk enriched with n-3 polyunsaturated fatty acids, oleic acid folic acid and vitamins E, B6 and B12 in volunteers with mild hyperlipidaemia. Nutrition 29:521–527, 2004.
13. F.Visioli, P.Risè, E.Plasmati, F.Pazzucconi, C.R.Sirtori, C.Galli:Very low intake of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerol and increase HDL-cholesterol in healthy subjects. Pharmacol Res 41:571–576, 2000.
14. P.Benito, J.Caballero, J.Moreno, C.Gutiérrez-Alcántara, C.Muñoz, G.Rojo, S.Garcia, F.C.Soriguer:Effects of milk enriched with n-3 fatty acids, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr 25:581–587, 2006.
15. ORIGIN Trial Investigators, J.Bosch, H.C.Gerstein, G.R.Dagenais, R.Díaz, L.Dyal, H.Jung, A.P.Maggiono, J.Probstfield, A.Ramachandran, M.C.Riddle, L.E.Rydén, S.Yusuf:n-3 fatty acids and cardiovascular outcomes in patients with hypoglycemia. N Engl J Med 367:309–318, 2012.
16. P.M.Ridker, M.J.Stampfer, N.Rifai:Novel risk factors for systemic atherosclerosis:a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481–2485, 2001.
17. J.Danesh, J.G.Wheeler, G.M.Hirschfield, S.Eda, G.Eiriksdottir, A.Rumley, G.D.Lowe, M.B.Pepys, V.Gudnason:C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397, 2004.
18. T.A.Mori, L.J.Beilin:Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 12:11–17, 2001.
19. C.C.Borghi, F.G.Arrigo:Recent evidence of the role of omega-3 polyunsaturated faty acids on blood pressure control and hypertension-related complications. Future Lipidol 1:569–577, 2006.
20. H.E.Theobald, A.H.Goodall, N.Sattar, D.C.Talbot, P.J.Chowienczyk, T.A.Sanders:Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr 137:973–978, 2007.
21. R.S.Dokholyan, C.M.Albert, L.J.Appel, N.R.Cook, P.Whelton, C.H.Hennekens:A trial of omega-3 fatty acids for prevention of hypertension. American J Cardiol 93:1041–1043, 2004.
22. J.Kopecky, M.Rossmeisl, P.Flachs, O.Kuda, P.Brauner, Z.Jilkova, B.Stankova, E.Tvrzicka, M.Bryhn:n-3 PUFA:bioavailability and modulation of adipose tissue function. Proc Nutr Soc 68:361–369, 2009.
23. A.Casado-Díaz, R.Santiago-Mora, G.Dorado, J.M.Quesada-Gómez:The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells:potential implication in osteoporosis. Osteoporos Int 24:1647–1661, 2013.
24. K.Yasunori, T.Masaaki, N.Tetsuyuki, K.Hayato, N.Akira:Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis. Clin Rheumatol 27:1093–1101, 2008.
25. J.A.Cauley, M.E.Danielson, G.A.Greendale, J.S.Finkelstein, Y.F.Chang, J.C.Lo, C.J.Crandall, R.M.Neer, K.Ruppert, L.Meyn, B.A.Prairie, M.R.Sowers:Bone resorption and fracture across the menopausal transition:the Study of Women's Health Across the Nation. Menopause 19:1200–1207, 2012.
26. L.A.Weiss, E.Barrett-Connor, D.von Muhlen:Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults:the Rancho Bernardo Study. Am J Clin Nutr 81:934–938, 2005.
27. P.Albertazzi, K.Coupland:Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas 20:13–22, 2002.
28. S.Papapoulos, R.Chapurlat, C.Libanati, M.L.Brandi, J.P.Brown, E.Czerwiński, M.A.Krieg, Z.Man, D.Mellström, S.C.Radominski, J.Y.Reginster, H.Resch, J.A.Román Ivorra, C.Roux, E.Vittinghoff, M.Austin, N.Daizadeh, M.N.Bradley, A.Grauer, S.R.Cummings, H.G.Bone:Five years of denosumab exposure in women with postmenopausal osteoporosis:results from the first two years of the FREEDOM extension. J Bone Miner Res 27:694–701, 2012.
29. P.Carpintero, E.Gil-Garay, D.Hernández-Vaquero, H.Ferrer, L.Munuera:Interventions to improve inpatient osteoporosis management following first osteoporotic fracture:the PREVENT project. Arch Orthop Trauma Surg 129:245–250, 2009.
30. S.Panizo, A.Cardus, M.Encinas, E.Parisi, P.Valcheva, S.López-Ongil, B.Coll, E.Fernández, J.M.Valdivielso:RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 104:1041–1048, 2009.
31. Received November 8, 2014; accepted December 23, 2014.